Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00350402 · ClinicalTrials.gov registry record · Phase 2
Masked Faces in Parkinson Disease: Mechanism and Treatment
A Phase 2 study of Parkinson's Disease, sponsored by University of Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT00350402 is a Phase 2 study of Parkinson's Disease that has completed, run by University of Florida. The registered enrollment target is 44 participants, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00350402, a Phase 2 study of Parkinson's Disease, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the effectiveness of high intensity respiratory muscle strength training in treating blunted facial expression in people with Parkinson disease.
Conditions Studied
Interventions
- BEHAVIORAL Respiratory muscle strength training
Study Locations (1)
Florida
- Cognitive Neuroscience Laboratory, L3-135, McKnight Brain Institute, University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2004-12 |
| Est. Completion | 2009-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00350402
The ClinicalTrials.gov registry entry for NCT00350402 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (93% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 1 intervention - of which Respiratory muscle strength training is the first listed.
NCT00350402 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT00350402 about?
NCT00350402 is a clinical study titled "Masked Faces in Parkinson Disease: Mechanism and Treatment". The purpose of this study is to examine the effectiveness of high intensity respiratory muscle strength training in treating blunted facial expression in people with Parkinson disease.
What is the current status of trial NCT00350402?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 44 participants. The study started on 2004-12. Estimated completion is 2009-11.
What conditions does trial NCT00350402 study?
This clinical trial studies the following conditions: Parkinson's Disease.
What interventions are being tested in trial NCT00350402?
The interventions under investigation include: Respiratory muscle strength training (BEHAVIORAL).
Who is sponsoring clinical trial NCT00350402?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00350402 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketamine for Veterans With Parkinson's Disease
RECRUITING · Phase 2
-
Imaging Depression in Parkinson's Disease
RECRUITING · Phase 2
-
Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease
RECRUITING · Phase 2
-
Tenapanor in Synucleinopathy-Related Constipation
RECRUITING · Phase 2
-
A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease
ACTIVE NOT RECRUITING · Phase 2
-
A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.